Holen Sie sich die Stockscreener-App
9.12
5.56%
0.48
Schlusskurs vom Vortag:
$8.64
Offen:
$8.7
24-Stunden-Volumen:
81,117
Relative Volume:
0.63
Marktkapitalisierung:
$48.47M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3755
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
+7.29%
1M Leistung:
+20.79%
6M Leistung:
-72.25%
1J Leistung:
-34.80%
1-Tages-Spanne:
$8.18
$9.215
1-Wochen-Bereich:
$8.18
$9.92
52-Wochen-Spanne:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
9.12 | 51.98M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
What analysts say about Aligos Therapeutics Inc. stockConsistent high-yield stocks - Autocar Professional
Is Aligos Therapeutics Inc. a good long term investmentRapid growth trajectories - Autocar Professional
What drives Aligos Therapeutics Inc. stock priceHigh-profit capital plays - jammulinksnews.com
How Aligos Therapeutics Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attentionOptimized Return Investment Picks - Newser
Aligos Therapeutics Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
What makes Aligos Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Aligos Therapeutics (ALGS) Grants Stock Options to New Employees - GuruFocus
Aligos Therapeutics Grants 2,100 Shares in Stock Options to New Hires with 4-Year Vesting Terms - Stock Titan
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
(ALGS) Investment Analysis and Advice - news.stocktradersdaily.com
Aligos Therapeutics Approves Major Amendments at Annual Meeting - TipRanks
Is Aligos Therapeutics, Inc. technically bullish or bearish? - MarketsMojo
How To Trade (ALGS) - news.stocktradersdaily.com
Aligos Therapeutics (ALGS) Welcomes New VP of Chemistry Manufacturing Controls | ALGS Stock News - GuruFocus
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing - Bluefield Daily Telegraph
Aligos Therapeutics Strengthens Drug Development Team: Former Kezar Executive to Drive Phase 2 Trial Progress - Stock Titan
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - Yahoo Finance
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Lis - GuruFocus
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - MarketScreener
Aligos Therapeutics (ALGS) Issues Stock Options to New Employees | ALGS Stock News - GuruFocus
Aligos Therapeutics Awards Major Stock Options Package: New Employees Get 26,000 Shares Under Nasdaq Rule - Stock Titan
(ALGS) Long Term Investment Analysis - news.stocktradersdaily.com
5,157 Shares in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Bought by Northern Trust Corp - Defense World
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Decline in Short Interest - Defense World
Clinical Stage Liver Disease Biotech Aligos Set for Major Jefferies Conference Presentation - Stock Titan
How the (ALGS) price action is used to our Advantage - news.stocktradersdaily.com
Financial Comparison: Entera Bio (NASDAQ:ENTX) versus Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Aligos Therapeutics (ALGS) Appoints New Head of Legal | ALGS Stock News - GuruFocus
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - The Manila Times
Former Genentech and Codexis Legal Leader Takes Top Legal Role at Liver Disease Biotech Aligos - Stock Titan
Aligos Therapeutics Issues 26,000-Share Inducement Grant To New Employee - Nasdaq
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Aligos Therapeutics (ALGS) Awards New Employee Stock Option Gran - GuruFocus
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):